Hidefumi Aoyama

About Hidefumi Aoyama

Hidefumi Aoyama, With an exceptional h-index of 45 and a recent h-index of 27 (since 2020), a distinguished researcher at Hokkaido University, specializes in the field of Radiation Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity …

Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy

Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan

A single-institution prospective study to evaluate the safety and efficacy of Real-time-image Gated spot-scanning Proton Therapy (RGPT) for prostate cancer

Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton (vol 96, 20220720, 2023)

Correction: Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma

Real-time tumor-tracking radiotherapy with SyncTraX for primary liver tumors requiring isocenter shift

Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective …

Hidefumi Aoyama Information

University

Position

___

Citations(all)

13146

Citations(since 2020)

5041

Cited By

9874

hIndex(all)

45

hIndex(since 2020)

27

i10Index(all)

110

i10Index(since 2020)

73

Email

University Profile Page

Google Scholar

Hidefumi Aoyama Skills & Research Interests

Radiation Oncology

Top articles of Hidefumi Aoyama

Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity …

Journal of Radiation Research

2024/3/17

Hiroshi Tamura
Hiroshi Tamura

H-Index: 43

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy

Radiation Oncology Journal

2024/3

Naoki Miyamoto
Naoki Miyamoto

H-Index: 3

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan

International Journal of Clinical Oncology

2024/3

Ken-Ichi Nibu
Ken-Ichi Nibu

H-Index: 25

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

A single-institution prospective study to evaluate the safety and efficacy of Real-time-image Gated spot-scanning Proton Therapy (RGPT) for prostate cancer

Advances in Radiation Oncology

2024/2/8

Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton (vol 96, 20220720, 2023)

The British Journal of Radiology

2023/4/1

Naoki Miyamoto
Naoki Miyamoto

H-Index: 3

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Correction: Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma

Discover Oncology

2024/1/25

Real-time tumor-tracking radiotherapy with SyncTraX for primary liver tumors requiring isocenter shift

Journal of Radiation Research

2024/1

Naoki Miyamoto
Naoki Miyamoto

H-Index: 3

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective …

Journal of Radiation Research

2024/1

Takayoshi Suzuki
Takayoshi Suzuki

H-Index: 38

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database

2023/6

Kazushi Maruo
Kazushi Maruo

H-Index: 11

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Effectiveness of CT‐image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk

Medical Physics

2023/6

A Japanese registry study and systematic review of particle therapy for renal cell carcinoma

2023/6

Kazushi Maruo
Kazushi Maruo

H-Index: 11

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Proton beam therapy for gliomas: a multicenter prospective registry study from all proton beam facilities in Japan

Journal of Radiation Research

2023/6

Yoshiki Arakawa
Yoshiki Arakawa

H-Index: 23

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

PO-1389 Prediction of daily GI doses in SBRT for pancreatic cancers using the shortest distance to GTV.

Radiotherapy and Oncology

2023/5/1

PO-2122 Effect of early fractional lymphocyte loss on lymphopenia probability models for NSCLC

Radiotherapy and Oncology

2023/5/1

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

Clinical and Translational Radiation Oncology

2023/3/1

Distribution of human papilloma virus genotypes and treatment outcomes in definitive radiotherapy for cervical cancer

Journal of Radiation Research

2023/3

Shuhei Takahashi
Shuhei Takahashi

H-Index: 11

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

A new predictive parameter for dose‐volume metrics in intensity‐modulated radiation therapy planning for prostate cancer: Initial phantom study

Journal of Applied Clinical Medical Physics

2023/12/25

Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study

Radiation Oncology

2023/2/7

Shuhei Takahashi
Shuhei Takahashi

H-Index: 11

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma

Discover Oncology

2023/12/8

Establishing quality indicators to comprehensively assess quality assurance and patient safety in radiotherapy and their relationship with an institution’s background

Radiotherapy and Oncology

2023/2/1

Yoshinori Ito
Yoshinori Ito

H-Index: 24

Hidefumi Aoyama
Hidefumi Aoyama

H-Index: 25

See List of Professors in Hidefumi Aoyama University(Hokkaido University)